PharmTech Drug Digest 11.20

All News


Adeline Siew Scientific Editor of Pharmaceutical Technology and Pharmaceutical Technology Europe talks to Joe Galati, Manager, Toxicology Services, Marvin Faber, Sr. Director, Global Head Environmental Health & Safety (EH&S), and Jeff Dinyer, Director EH&S & Global all from Patheon

Global biotechnology financing through the first nine months of 2013 shows that initial public offerings are on the rise while venture-capital funding stays relatively flat.